8-K: Aemetis Q3 2025: Revenue Up Sequentially, Net Loss Widens
Quarterly Report
Aemetis reported increased Q3 2025 revenue driven by India OMC orders and stronger ethanol, but also a wider net loss and operating loss compared to the prior year.
Summary
- Total revenues for the third quarter of 2025 were $59.2 million, an increase of $7 million from the prior quarter (Q2 2025), but a decrease from $81.4 million in Q3 2024.
- The company reported a gross loss of $58 thousand for Q3 2025, compared to a gross profit of $3.9 million in Q3 2024.
- Operating loss for Q3 2025 was $8.5 million, widening from an operating loss of $3.9 million in Q3 2024.
- Net loss for Q3 2025 was $23.7 million, compared to a net loss of $17.9 million in Q3 2024.
- Cash and cash equivalents increased to $5.6 million at the end of Q3 2025, up from $1.6 million in Q2 2025 and $900 thousand at the close of 2024.
- The Dairy Natural Gas segment produced 114,000 MMBtu from twelve operating dairy digesters, generating $4 million in revenue during Q3 2025.
- The India Biodiesel business recognized $14.5 million of revenue in Q3 2025, primarily from new allocations converted into sales to India Oil Marketing Companies.
- Aemetis signed an agreement with NPL Construction to build a $30 million Mechanical Vapor Recompression (MVR) system, expected to increase annual cash flow from operations by $32 million.
- The company plans to sell $20 million of Section 45Z and Section 48 tax credits after the September 2025 completion of the multi-dairy biogas digester.
- Investments in capital projects related to carbon intensity reduction and dairy digester construction totaled $4.1 million for Q3 2025 and $9.4 million for the first nine months of 2025.
Sentiment
Score: 4
Explanation: While revenue increased sequentially and there are positive project developments (MVR, biogas milestones, tax credits), the year-over-year financial performance shows significant deterioration with widening losses and declining gross profit, indicating underlying operational challenges despite strategic progress.
Positives
- Q3 2025 revenue increased by $7 million compared to Q2 2025, driven by India Oil Marketing Company orders and stronger ethanol prices/volumes.
- Cash increased to $5.6 million at the end of Q3 2025, up from $1.6 million in Q2 2025 and $900 thousand at the close of 2024, supporting project execution in India.
- The Biogas segment achieved a milestone with 12 operating digesters generating 114,000 MMBtu and $4 million in revenue, fully monetizing seven newly approved CARB RNG pathways.
- An agreement was signed for a $30 million Mechanical Vapor Recompression (MVR) system, expected to increase annual cash flow from operations by $32 million.
- The company secured $57 million of new equipment purchase and installation contracts for MVR and dairy RNG projects on favorable terms and without current shareholder dilution.
- Aemetis plans to sell $20 million of Section 45Z and Section 48 tax credits after the September 2025 completion of the multi-dairy biogas digester.
- The India subsidiary is targeting an IPO in 2026, and a CFO with IPO experience has joined the team.
Negatives
- Total revenues for Q3 2025 were $59.2 million, a decrease from $81.4 million for Q3 2024.
- Gross profit turned into a gross loss of $58 thousand for Q3 2025, compared to a $3.9 million gross profit during Q3 2024.
- Operating loss for Q3 2025 was $8.5 million, widening from an operating loss of $3.9 million for Q3 2024.
- Net loss for Q3 2025 was $23.7 million, compared to a net loss of $17.9 million for Q3 2024.
- Interest expense increased to $13 million during Q3 2025 compared to $11.7 million during Q3 2024.
- Revenues for the first nine months of 2025 were $154.3 million, down from $220.6 million for the first nine months of 2024, primarily due to reductions in biodiesel contracts in India.
- Gross loss for the first nine months of 2025 was $8.5 million, compared to a gross profit of $1.5 million during the first nine months of 2024.
- Operating loss for the first nine months of 2025 was $34.7 million, compared to $26.9 million for the first nine months of 2024.
- Net loss for the first nine months of 2025 was $71.7 million, slightly worse than the $71.3 million net loss during the same period of 2024.
- India Biodiesel Metric tons sold decreased significantly to 12.5 thousand in Q3 2025 from 26.0 thousand in Q3 2024, and to 21.0 thousand for the nine months ended September 30, 2025, from 73.5 thousand in the same period of 2024.
- The average price per RIN decreased to $2.37 in Q3 2025 from $3.37 in Q3 2024.
Risks
- Competition in the ethanol, RNG, biodiesel, and other industries in which the company operates.
- Commodity market risks, including those that may result from current weather conditions.
- Financial market risks.
- Customer adoption risks.
- Counter-party risks.
- Risks associated with changes to federal policy or regulation.
- Ability to fund, develop, build, maintain, and operate digesters, facilities, and pipelines for the dairy renewable natural gas segment.
- Ability to fund, develop, and operate SAF, renewable diesel, and carbon capture and sequestration projects, including obtaining required permits.
- Ability to receive awarded grants by meeting all of the required conditions, including meeting minimum contributions.
- Ability to repurchase the Series A preferred units relating to the Aemetis Biogas subsidiary and the expected valuation premium thereof.
- Ability to raise additional capital, including through a subsidiary IPO or other means.
Future Outlook
The company's five-year growth plan includes continued development and operation of digesters, facilities, and pipelines for its dairy renewable natural gas segment, as well as SAF, renewable diesel, and carbon capture and sequestration projects. It also anticipates receiving awarded grants by meeting required conditions and intends to repurchase Series A preferred units. The India subsidiary is targeting an IPO in 2026.
Management Comments
- "Revenues of $59.2 million during the third quarter of 2025 are an increase of $7 million from the prior quarter, reflecting continued execution across our California Ethanol and Dairy Renewable Natural Gas segments, and fulfillment of new India Oil Marketing Companies orders." Todd Waltz, Chief Financial Officer.
- "We are pleased with third-quarter revenues for biogas that fully monetize the seven newly approved CARB RNG pathways." Todd Waltz, Chief Financial Officer.
- "The MVR system will positively improve the economics of our fuel ethanol business, and is expected to add $32 million to annual cash flow from operations." Eric McAfee, Chairman and CEO.
- "We have signed $57 million of new equipment purchase and installation contracts for the MVR and dairy RNG projects this year on favorable terms and without current shareholder dilution." Eric McAfee, Chairman and CEO.
- "After the September 2025 completion of the multi-dairy biogas digester, we are now planning to sell $20 million of Section 45Z and Section 48 tax credits." Eric McAfee, Chairman and CEO.
Industry Context
Aemetis operates in the renewable natural gas and renewable fuels sector, focusing on low and negative carbon intensity products. The company's expansion in dairy biogas and investment in MVR systems align with broader industry trends towards decarbonization and sustainable energy production. The India biodiesel business's reliance on government-owned Oil Marketing Companies highlights the influence of national energy policies on renewable fuel markets. The pursuit of Section 45Z and 48 tax credits underscores the importance of government incentives in driving renewable energy project economics.
Stakeholder Impact
- Shareholders: Potential for increased cash flow from the MVR system ($32 million annually) and future tax credit sales ($20 million) could benefit shareholders. However, widening net losses and operating losses could negatively impact share value. The potential India subsidiary IPO could unlock value.
- Customers: Continued operation and expansion of renewable natural gas and ethanol production ensures supply of low-carbon fuels and animal feed.
- Employees: Continued investment in projects like MVR and dairy digesters suggests ongoing operational activity and potential for job stability or growth.
- Creditors: Increased interest expense and significant current portion of long-term debt ($266.1 million) could be a concern, though increased cash balance provides some liquidity.
Next Steps
- Build a $30 million Mechanical Vapor Recompression (MVR) system.
- Sell $20 million of Section 45Z and Section 48 tax credits after the September 2025 completion of the multi-dairy biogas digester.
- India subsidiary targeting an IPO in 2026.
- Continue funding, developing, building, maintaining, and operating digesters, facilities, and pipelines for the dairy renewable natural gas segment.
- Continue funding, developing, and operating SAF, renewable diesel, and carbon capture and sequestration projects.
- Obtain required permits for SAF, renewable diesel, and carbon capture and sequestration projects.
- Meet required conditions for awarded grants, including minimum contributions.
- Repurchase Series A preferred units relating to the Aemetis Biogas subsidiary.
Key Dates
| Date | Description |
|---|---|
| September 2025 | Completion of the multi-dairy biogas digester. |
| September 30, 2025 | End of the three and nine months financial reporting period. |
| November 6, 2025 | Date of earliest event reported and issuance of the press release announcing earnings. |
| November 6, 2025 | Earnings review call at 11:00 a.m. Pacific time (PT). |
| 2026 | India subsidiary targeting an IPO. |
Recommendation
holdWhile Aemetis shows promising strategic developments in renewable natural gas and carbon intensity reduction projects, evidenced by increased cash and new contracts, the significant year-over-year deterioration in core financial metrics (revenue, gross profit, operating loss, net loss) presents a mixed picture. The long-term potential from the MVR system and tax credit sales is positive, but current profitability challenges and high debt levels warrant caution. A "Hold" recommendation allows investors to monitor the execution of these strategic initiatives and observe improvements in financial performance before making further commitments.
Keywords
Aemetis, AMTX, Q3 2025 earnings, financial results, renewable natural gas, RNG, ethanol, biodiesel, sustainable aviation fuel, SAF, carbon intensity, MVR system, dairy digesters, India Oil Marketing Company, Section 45Z, Section 48 tax credits, clean energy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.